Efficacy of Adding Oral Simvastatin to Topical Therapy for Treatment of Psoriasis: The Vietnamese Experience

BACKGROUND: Psoriasis, the prevalence of which ranges from 2% to 3% of the general population, has been recently recognised as not only a chronic inflammatory skin disorder but also an immunometabolic systemic disease. Dyslipidemia is one of the most important comorbidities of psoriasis. Statins, fr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Access Maced J Med Sci
Autors principals: Trong, Hao Nguyen, Tat, Thang Nguyen, Anh, Tu Tran Nguyen, Uyen, Nhi Pham, Van, Thuong Nguyen, Hau, Khang Tran, Gandolfi, Marco, Satolli, Francesca, Feliciani, Claudio, Tirant, Michael, Vojvodic, Aleksandra, Lotti, Torello
Format: Artigo
Idioma:Inglês
Publicat: Republic of Macedonia 2019
Matèries:
Clinical Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364708/
https://ncbi.nlm.nih.gov/pubmed/30745969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2019.060
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars